XML 31 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Changes in Equity - CAD ($)
$ in Thousands
Total
Share capital
Contributed surplus
Retained earnings
Currency translation adjustments
Cash flow hedge reserve
Total accumulated other comprehensive income
Non-controlling interests
Beginning balance at Mar. 31, 2022 $ 985,683 $ 530,241 $ 11,734 $ 416,773 $ 24,412 $ (1,564) $ 22,848 $ 4,087
Changes in equity [abstract]                
Net income 127,701     127,433       268
Other comprehensive income (loss) 41,035     3,644 26,794 10,398 37,192 199
Comprehensive income 168,736     131,077 26,794 10,398 37,192 467
Non-controlling interest (452)     367       (819)
Stock-based compensation 5,088   5,088          
Exercise of stock options 4,964 6,318 (1,354)          
Common shares held in trust (12,365) (12,365)            
Repurchase of common shares (21,071) (3,561)   (17,510)        
Ending balance at Mar. 31, 2023 1,130,583 520,633 15,468 530,707 51,206 8,834 60,040 3,735
Changes in equity [abstract]                
Net income 194,181     193,735       446
Other comprehensive income (loss) 3,475     (406) (2,571) 6,686 4,115 (234)
Comprehensive income 197,656     193,329 (2,571) 6,686 4,115 212
Non-controlling interest (195)     471       (666)
Stock-based compensation 11,253   11,253          
Exercise of stock options 2,152 2,754 (602)          
U.S. initial public offering (note 17) 366,332 366,332            
Common shares held in trust (23,820) (23,820)            
Repurchase of common shares (14) (2)   (12)        
Ending balance at Mar. 31, 2024 $ 1,683,947 $ 865,897 $ 26,119 $ 724,495 $ 48,635 $ 15,520 $ 64,155 $ 3,281